Metropolitan Life Insurance Company (MetLife)’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,500
| Closed | -$77.4K | – | 1716 |
|
|
2024
Q1 | $77.4K | Sell |
1,500
-140
| -9% | -$7.22K | ﹤0.01% | 1192 |
|
|
2023
Q4 | $66.1K | Buy |
1,640
+101
| +7% | +$4.07K | ﹤0.01% | 1298 |
|
|
2023
Q3 | $42.9K | Buy |
1,539
+134
| +10% | +$3.74K | ﹤0.01% | 1495 |
|
|
2023
Q2 | $40.5K | Hold |
1,405
| – | – | ﹤0.01% | 1555 |
|
|
2023
Q1 | $23.4K | Hold |
1,405
| – | – | ﹤0.01% | 1799 |
|
|
2022
Q4 | $17.8K | Hold |
1,405
| – | – | ﹤0.01% | 2076 |
|
|
2022
Q3 | $16.9K | Hold |
1,405
| – | – | ﹤0.01% | 2103 |
|
|
2022
Q2 | $19.8K | Buy |
+1,405
| New | +$19.8K | ﹤0.01% | 2058 |
|